Michael Quinn
Head of Quality Control
- Role
- Head of Quality Control at Medipost Inc
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Michael Quinn
Biotech Quality professional with over 20 years of leadership, technical and operational…
Experience
Head of Quality Control
Sep 2024 — Present
Founded in 2012, MEDIPOST, Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases. The company\'s flagship product, CARTISTEM®, is the world\'s first allogeneic stem cell therapy for knee osteoarthritis (OA), approved in Korea in 2012 and used to treat over patients. Following its Phase 1/2a U.S. clinical trial, MEDIPOST, Inc. is now preparing its IND to begin a Phase study.
Education
University of Vermont
BS, Biological Science
1991 — 1995
Skills
- Gmp
- Pharmaceutical Industry
- Life Sciences
- Biotechnology
- Cell Culture
- Drug Discovery
- Biopharmaceuticals
- Assay Development
- Validation
- Standard Operating Procedure (Sop)
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.